With technical advancements and raising prevalence of cataracts and refractive errors, the market for intraocular lenses (IOLs) is reaching to (Dollar) 5.2bn by 2030.
People discharged from hospital after covid-19 appear to have increased rates of organ damage ("multiorgan dysfunction") compared with similar individuals in the general population.